Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 77 matching records.
77 results — page 1 of 4
- Level DAnimal StudyEurope PMC
Antibody-conjugated mesenchymal stromal cell drug delivery system for the treatment of autoimmune diseases in mice
Animal Study on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Nat Commun (2026) — summary generated from the PubMed abstract.
- 2026
Nat Commun2 citations - Level DAnimal StudyPubMed
Safety and biodistribution of intrathecal administration of mesenchymal stem cells (MSCs) and neurotrophin-releasing nanoparticles in a porcine CSF-guided delivery model for amyotrophic lateral sclerosis (ALS) drug disco
Animal Study on Neuroinflammation, Chronic Inflammation, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level DNarrative ReviewEurope PMC
Mechanisms and Drug-Augmenting Strategies of Mesenchymal Stem Cells for Preserving β-Cell in Type 2 Diabetes
Narrative Review on Type 2 Diabetes, published in Drug Des Devel Ther (2026) — summary generated from the PubMed abstract.
- 2026
Drug Des Devel Ther - Level DNarrative ReviewEurope PMC
Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
Narrative Review on Chronic Inflammation, Immune Modulation, published in Drug Deliv Transl Res (2025) — summary generated from the PubMed abstract.
- 2025
Drug Deliv Transl Res5 citations - Level DAnimal StudyEurope PMC
Mesenchymal Stem Cells with Simultaneous Overexpression of GPX3 and CD47 for the Treatment of Drug-Induced Acute Liver Injury
Animal Study on Face & Skin, Systemic / IV, published in Vet Sci (2025) — summary generated from the PubMed abstract.
- 2025
Vet Sci2 citations - Level DAnimal StudyPubMed
The Transfer of USP25 by Exosomes of Adipose Tissue-Derived Mesenchymal Stem Cells Ameliorates Diabetic Nephropathy Through Stabilizing SMAD7 Expression.
Animal Study on Type 2 Diabetes, Chronic Kidney Disease, published in Chem Biol Drug Des (2025) — summary generated from the PubMed abstract.
- 2025
Chem Biol Drug Des4 citations - Level DNarrative ReviewEurope PMC
Integrating Graphene Oxide and Mesenchymal Stem Cells in 3D-Printed Systems for Drug Delivery and Tissue Regeneration
Narrative Review on Immune Modulation, published in Pharmaceutics (2025) — summary generated from the PubMed abstract.
- 2025
Pharmaceutics2 citations - Level DLaboratory StudyPubMed
The Preservation of the Therapeutic Efficacy of the Secretome of Adipose Mesenchymal Stem Cells, Produced in the Presence of Antioxidant and Anti-Inflammatory Drugs.
Laboratory Study on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Pharmaceutics (2025) — summary generated from the PubMed abstract.
- 2025
Pharmaceutics - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell-Mediated Targeted Drug Delivery Systems for Hepatocellular Carcinoma: Current Advances and Future Directions
Narrative Review on Immune Modulation, published in Bioengineering (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Bioengineering (Basel)1 citations - Level DLaboratory StudyEurope PMC
Impact of Anti-Mycotic Drugs on the Osteogenic Response of Bone Marrow Mesenchymal Stem Cells In Vitro
Laboratory Study on Hip, Systemic / IV, published in Antibiotics (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Antibiotics (Basel) - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived exosomes as a new drug carrier for the treatment of spinal cord injury: A review
Narrative Review on Spinal Cord Injury, Chronic Inflammation, published in Chin J Traumatol (2024) — summary generated from the PubMed abstract.
- 2024
Chin J Traumatol12 citations - Level DNarrative ReviewPubMed
Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents.
Narrative Review on Face & Skin, published in J Drug Target (2024) — summary generated from the PubMed abstract.
- 2024
J Drug Target - Level DLaboratory StudyPubMed
Mesenchymal Stem Cells Increase Drug Tolerance of A431 Cells Only in 3D Spheroids, Not in 2D Co-Cultures.
Laboratory Study, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci - Level DAnimal StudyPubMed
Extracellular Vesicles Derived from H 2 O 2 -Stimulated Adipose-Derived Stem Cells Alleviate Senescence in Diabetic Bone Marrow Mesenchymal Stem Cells and Restore Their Osteogenic Capacity.
Animal Study on Systemic / IV, published in Drug Des Devel Ther (2024) — summary generated from the PubMed abstract.
- 2024
Drug Des Devel Ther6 citations - Level DLaboratory StudyEurope PMC
Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure
Laboratory Study on Cardiovascular Disease, Immune Modulation, published in World J Cardiol (2024) — summary generated from the PubMed abstract.
- 2024
World J Cardiol2 citations - Level CProspective StudyPubMed
Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen.
Prospective Study, published in Cells (2023) — summary generated from the PubMed abstract.
- 2023
Cells - Level DNarrative ReviewPubMed
Mesenchymal stem cells: a trojan horse to treat glioblastoma.
Narrative Review on Face & Skin, published in Invest New Drugs (2023) — summary generated from the PubMed abstract.
- 2023
Invest New Drugs - Level CProspective StudyPubMed
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Prospective Study with a reported sample of 46 on Immune Modulation, published in Ann Hematol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 46
Ann Hematol - Level DAnimal StudyEurope PMC
Wound Restorative Power of Halimeda macroloba / Mesenchymal Stem Cells in Immunocompromised Rats via Downregulating Inflammatory/Immune Cross Talk
Animal Study on Chronic Wound, Chronic Inflammation, published in Mar Drugs (2023) — summary generated from the PubMed abstract.
- 2023
Mar Drugs7 citations - Level DLaboratory StudyEurope PMC
The Effect of Mesenchymal Stem Cells Derived-Conditioned Media in Combination with Oral Anti-Androgenic Drugs on Male Pattern Baldness: An Animal Study
Laboratory Study on Hair Loss, Hair Regeneration, published in Cell J (2023) — summary generated from the PubMed abstract.
- 2023
Cell J2 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review
Narrative Review on Diabetic Foot, Chronic Wound, published in World J Diabetes (2023) — summary generated from the PubMed abstract.
- 2023
World J Diabetes7 citations - Level DAnimal StudyEurope PMC
Controlled Release of Mesenchymal Stem Cell-Conditioned Media from a Microsphere/Gel-Based Drug Delivery System for Wound Healing of Tympanic Membrane Perforations
Animal Study on Chronic Wound, published in J Tissue Eng Regen Med (2023) — summary generated from the PubMed abstract.
- 2023
J Tissue Eng Regen Med - Level DAnimal StudyPubMed
Gene-Directed Enzyme/Prodrug Therapy of Rat Brain Tumor Mediated by Human Mesenchymal Stem Cell Suicide Gene Extracellular Vesicles In Vitro and In Vivo.
Animal Study, published in Cancers (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Cancers (Basel) - Level DLaboratory StudyPubMed
Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery.
Laboratory Study on Stroke Research, Chronic Inflammation, Immune Modulation, published in Front Bioeng Biotechnol (2022) — summary generated from the PubMed abstract.
- 2022
Front Bioeng Biotechnol26 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406